China Executes Former Food And Drug Head
This article was originally published in PharmAsia News
Executive Summary
China executed Zheng Xiaouy, the former head of the State Food and Drug Administration, July 10 for dereliction of duty and for accepting $850,000 worth of bribes from pharmaceutical companies, according to the official Xinhua news service
You may also be interested in...
Silver Lining: Will GSK Case Increase Compliance In China?
Although it promises to be a bumpy road, the GSK investigation could lead to a more compliant health care industry with Chinese anti-bribery laws acting as a more forceful deterrent to local players than the U.S. Foreign Corrupt Practices Act.
Putting GSK’s China Bribery Crisis In Context
GSK’s China bribery crisis stems in part from a poorly managed and financed public-hospital system that relies on drug sales and markups to survive. The question is, will the government make reforms soon enough, and what should companies do in the meantime?
Putting GSK’s China Bribery Crisis In Context
GSK’s China bribery crisis stems in part from a poorly managed and financed public-hospital system that relies on drug sales and markups to survive. The question is, will the government make reforms soon enough, and what should companies do in the meantime?